Obituaries
PGe
PG Store
Archives
Classifieds
Classified
Events
Jobs
Real Estate
Legal Notices
Pets
MENU
SUBSCRIBE
LOGIN
REGISTER
LOG OUT
MY PROFILE
Home
News
Local
Sports
Opinion
A&E
Life
Business
Contact Us
NEWSLETTERS
MENU
ACCOUNT
Subscribe
Login
Register
Log out
My Profile
Subscriber Services
Search
SECTIONS
HOME
Homepage
This Just In
Chats
Weather
Traffic
Event Guide
PG Store
PGe
Video
Photos
The Digs
RSS Feeds
NEWS
News Home
COVID-19
World
Nation
State
Obituaries
News Obituaries
Politics
Education
Portfolio
Science
Health & Wellness
Environment
Aging Edge
Transportation
Faith & Religion
Crimes & Courts
Social Services
LOCAL
Local Home
Region
City
North
East
West
South
Washington
Westmoreland
The Neighborhood
Obituaries
Classifieds
Legal Notices
Real Estate
SPORTS
Sports Home
Steelers
Penguins
Pirates
Sports Columns
Gene Collier
Ron Cook
Joe Starkey
Paul Zeise
High School Sports
College Sports
Pitt
Penn State
WVU
NCAA
NFL
MLB
NBA
NHL
North Shore Drive Podcast
OPINION
Opinion Home
Editorials
Letters
Op-Ed Columns
PG Columnists
Insight
A&E
A&E Home
Celebrities
Movies
TV & Radio
Music
Concert Listings
Theatre & Dance
Art & Architecture
Books
Events
LIFE
Life Home
Food
Buying Here
Homes & Gardens
Style & Fashion
Travel
Restaurants
Seen
goodness
Random Acts of Kindness
Pets
Beer Me
Outdoors
Holidays
BUSINESS
Business Home
Your Money
Wheels
Workzone
Business Health
Tech News
Building PGH
Powersource
Business / Law
Top Workplaces
Business of Pittsburgh
Consumer Alerts
OTHER
PGe
NEWSLETTERS
PG STORE
ARCHIVES
CLASSIFIEDS
OBITUARIES
JOBS
LEGAL NOTICES
REAL ESTATE
CLASSIFIEDS
EVENTS
PETS
CONTACT US / FAQ
CONTACT US
ADVERTISING
CAREER OPPORTUNITIES
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Virpax Pharmaceuticals, Inc. - Common Stock
(NQ:
VRPX
)
0.6695
UNCHANGED
Last Price
Updated: 4:00 PM EDT, Apr 3, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Virpax Pharmaceuticals, Inc. - Common Stock
< Previous
1
2
...
4
5
6
7
8
9
10
11
Next >
55 Biggest Movers From Yesterday
↗
July 09, 2021
Gainers Moving iMage Technologies, Inc. (NYSE: MITQ) shares jumped 700% to settle at $24.00 on Thursday. Moving iMage Technologies priced its initial public offering of 4.2...
Via
Benzinga
31 Stocks Moving in Thursday's Pre-Market Session
↗
July 08, 2021
Gainers TESSCO Technologies Incorporated (NASDAQ: TESS) shares rose 46% to $8.41 in pre-market trading after the company reported strong preliminary results for its first quarter...
Via
Benzinga
The Daily Biotech Pulse: Priority Review For Amgen's Asthma Treatment, Evaxion Reports Positive Skin Cancer Readout, Quidel Recalls Lyra COVID-19 Test
↗
July 08, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 7) Ambrx Biopharma Inc. (NYSE:...
Via
Benzinga
Topics
Product Recall
61 Biggest Movers From Yesterday
↗
July 08, 2021
Gainers Newegg Commerce, Inc. (NASDAQ: NEGG) shares surged 148.4% to close at $67.57 on Wednesday after jumping around 42% on Tuesday. Mannatech, Incorporated (NASDAQ: MTEX)...
Via
Benzinga
Virpax Pharmaceuticals Provides Progress Update on Product Candidates
July 07, 2021
From
Virpax Pharmaceuticals Inc.
Via
Business Wire
20 Stocks Moving in Thursday's Pre-Market Session
↗
July 01, 2021
Gainers Alterity Therapeutics Ltd (NASDAQ: ATHE) shares rose 64% to $2.14 in pre-market trading. Alterity Therapeutics recently said it received EU regulatory guidance for ATH434...
Via
Benzinga
The Daily Biotech Pulse: Gemini Sinks On Data, Amgen's Migraine Drug Approved In Japan, Liver Congress Gets Underway
↗
June 23, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs June 22) AngioDynamics, Inc. (NASDAQ...
Via
Benzinga
Virpax to Use Envelta™ IND Enabling Study Results for Two Additional Indications
June 21, 2021
From
Virpax Pharmaceuticals
Via
Business Wire
Virpax Pharmaceuticals to Present at LD Micro Invitational XI Event on Wednesday, June 9th at 4:30 PM ET
June 02, 2021
From
Virpax Pharmaceuticals, Inc.
Via
Business Wire
Virpax Pharmaceuticals Reports 2021 First Quarter Results and Recent Developments
May 18, 2021
From
Virpax Pharmaceuticals, Inc.
Via
Business Wire
60 Biggest Movers From Yesterday
↗
May 27, 2021
Gainers Lizhi Inc. (NASDAQ: LIZI) shares surged 57.6% to close at $6.84 on Wednesday. Flywire Corporation (NASDAQ: FLYW) gained 46.3% to settle at $35.10 after the company priced...
Via
Benzinga
22 Stocks Moving in Monday's Pre-Market Session
↗
May 03, 2021
Gainers Brooklyn ImmunoTherapeutics, Inc. (NYSE: BTX) rose 58.3% to $78.90 in pre-market trading. Nicholas Jason Singer disclosed a 9.13% passive stake in Brooklyn...
Via
Benzinga
The Daily Biotech Pulse: Spero Secures NIAID Funding, GlaxoSmithKline Releases COVID-19 Data, BioNTech Gets New CFO
↗
May 18, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 17) Alexion Pharmaceuticals, Inc...
Via
Benzinga
Virpax Pharmaceuticals Engages Torreya Capital to Advise on Global Partnering Efforts
April 22, 2021
From
Virpax Pharmaceuticals, Inc.
Via
Business Wire
The Daily Biotech Pulse: CorMedix Slumps On Delay In Resubmission of DefenCath NDA, Apellis Awaits FDA Decision, Vera Therapeutics Debuts
↗
May 14, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 13) Alexion Pharmaceuticals, Inc...
Via
Benzinga
The Daily Biotech Pulse: Q1 Beat From Johnson & Johnson, KalVista Study Placed On Hold, European Label Expansion For GW Pharma's Epidiolex
↗
April 20, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs April 15) Alexion Pharmaceuticals,...
Via
Benzinga
Virpax's Anti-Viral Candidate Reduced Nasal, Brain Viral Load In Animal Study
↗
April 19, 2021
Virpax Pharmaceuticals Inc (NASDAQ: VRPX) has announced preclinical results of MMS019, its anti-viral product candidate for respiratory viruses. MMS019 is a...
Via
Benzinga
Virpax’s MMS019 Reduced Nasal and Brain Viral Load in Animal Study
April 19, 2021
From
Virpax Pharmaceuticals, Inc.
Via
Business Wire
51 Biggest Movers From Friday
↗
April 12, 2021
Gainers Celcuity Inc. (NASDAQ: CELC) shares climbed 50.9% to close at $21.60 on Friday after the company announced a worldwide licensing agreement with Pfizer to develop and...
Via
Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
↗
April 09, 2021
Gainers GT Biopharma (NASDAQ:GTBP) stock increased by 17.4% to $10.32 during Friday's regular session. Trading volume for this security as of 12:32 EST is 558.4K,...
Via
Benzinga
38 Stocks Moving In Friday's Mid-Day Session
↗
April 09, 2021
Gainers Celcuity Inc. (NASDAQ: CELC) shares jumped 64.5% to $23.54 after the company announced a worldwide licensing agreement with Pfizer to develop and commercialize...
Via
Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
↗
April 09, 2021
Gainers Greenwich LifeSciences (NASDAQ:GLSI) stock moved upwards by 32.67% to $67.0 during Friday's pre-market session. The company's market cap stands at $860.7...
Via
Benzinga
30 Stocks Moving in Friday's Pre-Market Session
↗
April 09, 2021
Gainers Celcuity Inc. (NASDAQ: CELC) rose 32.3% to $19.00 in pre-market trading after the company reported a worldwide licensing agreement with Pfizer to develop and...
Via
Benzinga
44 Biggest Movers From Yesterday
↗
April 09, 2021
Gainers Chemomab Therapeutics Ltd. (NASDAQ: CMMB) shares jumped 111.5% to close at $55.00 on Thursday. ORBCOMM Inc. (NASDAQ: ORBC) gained 52.1% to close at $11.51 on Thursday. GI...
Via
Benzinga
< Previous
1
2
...
4
5
6
7
8
9
10
11
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story
Your e-mail:
Friends e-mail:
Submit
